New clinical data from the STEM-PD Phase I/II clinical trial have been presented at the ISSCR 2026 Annual Meeting. The study ...
New, previously unpublished clinical data have been presented at ISSCR 2026 demonstrating that transplanted human neural ...
Tooth enamel is the hardest substance in the human body, yet once damaged, it cannot regenerate naturally. To overcome this ...
Blind People Offered Hope of Seeing Again After Stem Cell Breakthrough Remakes Retinal Blood Vessels
When injected into mice with retinal disease, the special retinal blood cells integrated into the damaged tissue to ...
Morning Overview on MSN
The FDA approved a cell therapy to curb a deadly complication of stem-cell transplants
Children who survive a stem-cell transplant only to watch their own donor cells attack their organs now have a ...
Americans Skip Overseas Travel as Stem Cell Therapy Arrives at 5 U.S. Locations Aventura, United States - July 5, 2026 ...
The human-made cells show many hallmarks of life, but they can't make all their necessary internal structures or divide for ...
The STEM-PD research team will now continue the long-term follow-up of the participants to further evaluate safety, graft function, and clinical benefit.
In an interview, synthetic biologist Peter Carr explains research on synthetic cells, their potential benefits and hazards, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results